UB Paderborn / Katalog / Suche / in CDI

Central Nervous System Penetration of Antiretroviral Drugs: Pharmacokinetic, Pharmacodynamic and Pharmacogenomic Considerations

Clinical pharmacokinetics, 2015-06, Vol.54 (6), p.581-598

2015

Volltextzugriff (PDF)

Minimizing the impact of the triple burden of COVID-19, tuberculosis and HIV on health services in sub-Saharan Africa

International journal of infectious diseases, 2021-12, Vol.113, p.S16-S21

2021

Volltextzugriff (PDF)

The 12-month period prevalence and cardiac manifestations of HIV in patients with acute coronary syndrome at a tertiary hospital in Cape Town, South Africa: a retrospective cross-sectional study

BMC infectious diseases, 2021-07, Vol.21 (1), p.1-657, Article 657

2021

Volltextzugriff (PDF)

Incident tuberculosis disease in patients receiving biologic therapies in the Western Cape, South Africa from 2007 to 2018

BMC infectious diseases, 2020-11, Vol.20 (1), p.900-8, Article 900

2020

Volltextzugriff (PDF)

A preliminary review of warfarin toxicity in a tertiary hospital in Cape Town, South Africa

Cardiovascular Journal of Africa, 2017-11, Vol.28 (6), p.346-349

2017

Volltextzugriff (PDF)

The safety, effectiveness and concentrations of adjusted lopinavir/ritonavir in HIV-infected adults on rifampicin-based antitubercular therapy

PloS one, 2012-03, Vol.7 (3), p.e32173

2012

Volltextzugriff (PDF)

Pharmacokinetics of Lopinavir in HIV-Infected Adults Receiving Rifampin with Adjusted Doses of Lopinavir-Ritonavir Tablets

Antimicrobial Agents and Chemotherapy, 2011-07, Vol.55 (7), p.3195-3200

2011

Volltextzugriff (PDF)

Neuronal toxicity of efavirenz: a systematic review

Expert opinion on drug safety, 2013-11, Vol.12 (6), p.841-846

2013

Volltextzugriff (PDF)

Pharmacokinetics of Antimicrobials in Children with Emphasis on Challenges Faced by Low and Middle Income Countries, a Clinical Review

Antibiotics (Basel), 2022-12, Vol.12 (1), p.17

2022

Volltextzugriff (PDF)

Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis

Clinical pharmacokinetics, 2019-09, Vol.58 (9), p.1103-1129

2019

Volltextzugriff (PDF)

Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings

The American journal of tropical medicine and hygiene, 2020-06, Vol.102 (6), p.1184-1188

2020

Volltextzugriff (PDF)

Pharmacogenetics of tenofovir and emtricitabine penetration into cerebrospinal fluid

Southern African journal of HIV medicine, 2021, Vol.22 (1), p.1206-e24

2021

Volltextzugriff (PDF)

How COVID-19 has fundamentally changed clinical research in global health

The Lancet global health, 2021-05, Vol.9 (5), p.e711-e720

2021

Volltextzugriff (PDF)

Single Dose Abacavir Pharmacokinetics and Safety in Neonates Exposed to Human Immunodeficiency Virus (HIV)

Clinical infectious diseases, 2021-06, Vol.72 (11), p.2032-2034

2021

Volltextzugriff (PDF)

Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trial

American journal of obstetrics and gynecology, 2018-10, Vol.219 (4), p.388.e1-388.e17

2018

Volltextzugriff (PDF)

Current trends in drug treatment of obsessive-compulsive disorder

Neuropsychiatric disease and treatment, 2010-05, Vol.6 (1), p.233-242

2010

Volltextzugriff (PDF)

Pharmacogenetics of the Late-Onset Efavirenz Neurotoxicity Syndrome (LENS)

Clinical infectious diseases, 2022-08, Vol.75 (3), p.399-405

2022

Volltextzugriff (PDF)

Evaluation of the Effectiveness of Dose Individualization to Achieve Therapeutic Vancomycin Concentrations

Journal of clinical pharmacology, 2018-09, Vol.58 (9), p.1134-1139

2018

Volltextzugriff (PDF)

Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19

The American journal of tropical medicine and hygiene, 2020-10, Vol.103 (4), p.1364-1366

2020

Volltextzugriff (PDF)

Pharmacogenetics and pharmacokinetics of CNS penetration of efavirenz and its metabolites

Journal of antimicrobial chemotherapy, 2019-03, Vol.74 (3), p.699-709

2019

Volltextzugriff (PDF)

Moderate to severe HIV-associated neurocognitive impairment: A randomized placebo-controlled trial of lithium

Medicine (Baltimore), 2016-11, Vol.95 (46), p.e5401

2016

Volltextzugriff (PDF)

Clinical trials of disease stages in COVID 19: complicated and often misinterpreted

The Lancet global health, 2020-10, Vol.8 (10), p.e1249-e1250

2020

Volltextzugriff (PDF)

Population pharmacokinetics of esomeprazole in patients with preterm preeclampsia

British journal of clinical pharmacology, 2022-10, Vol.88 (10), p.4639-4645

2022

Volltextzugriff (PDF)

Pediatric Antiretroviral Therapeutic Drug Monitoring: A Five and a Half Year Experience from a South African Tertiary Hospital

Journal of tropical pediatrics (1980), 2020-08, Vol.66 (4), p.385-394

2020

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Central Nervous System Penetration of Antiretroviral Drugs: Pharmacokinetic, Pharmacodynamic and Pharmacogenomic Considerations

Minimizing the impact of the triple burden of COVID-19, tuberculosis and HIV on health services in sub-Saharan Africa

The 12-month period prevalence and cardiac manifestations of HIV in patients with acute coronary syndrome at a tertiary hospital in Cape Town, South Africa: a retrospective cross-sectional study

Incident tuberculosis disease in patients receiving biologic therapies in the Western Cape, South Africa from 2007 to 2018

A preliminary review of warfarin toxicity in a tertiary hospital in Cape Town, South Africa

The safety, effectiveness and concentrations of adjusted lopinavir/ritonavir in HIV-infected adults on rifampicin-based antitubercular therapy

Pharmacokinetics of Lopinavir in HIV-Infected Adults Receiving Rifampin with Adjusted Doses of Lopinavir-Ritonavir Tablets

Neuronal toxicity of efavirenz: a systematic review

Pharmacokinetics of Antimicrobials in Children with Emphasis on Challenges Faced by Low and Middle Income Countries, a Clinical Review

Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis

Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings

Pharmacogenetics of tenofovir and emtricitabine penetration into cerebrospinal fluid

How COVID-19 has fundamentally changed clinical research in global health

Single Dose Abacavir Pharmacokinetics and Safety in Neonates Exposed to Human Immunodeficiency Virus (HIV)

Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trial

Current trends in drug treatment of obsessive-compulsive disorder

Pharmacogenetics of the Late-Onset Efavirenz Neurotoxicity Syndrome (LENS)

Evaluation of the Effectiveness of Dose Individualization to Achieve Therapeutic Vancomycin Concentrations

Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19

Clinical characteristics associated with mortality of COVID-19 patients admitted to an intensive care unit of a tertiary hospital in South Africa

Pharmacogenetics and pharmacokinetics of CNS penetration of efavirenz and its metabolites

Moderate to severe HIV-associated neurocognitive impairment: A randomized placebo-controlled trial of lithium

Clinical trials of disease stages in COVID 19: complicated and often misinterpreted

Population pharmacokinetics of esomeprazole in patients with preterm preeclampsia

Pediatric Antiretroviral Therapeutic Drug Monitoring: A Five and a Half Year Experience from a South African Tertiary Hospital

Suchergebnisse filtern